PreparationsIsoforms m-tyramine hydroxylation K m [µM] V max [pmol/pmol CYP/min] Cl V max / K m Supersomes (Gentest) ( 0,36 mg protein/ml) Rat CYP2D2 –

Slides:



Advertisements
Similar presentations
Cytochrome P450s in Humans David Nelson Feb. 4, 2009
Advertisements

Chapter 5 Opener. 5.1 Structural features of catecholamines.
Interactions Between Reward and Stress Systems
The Expression of NPPA Splice Variants During Cardiac Differentiation of Mouse Mesenchymal and Embryonic Stem Cells Masoumeh Fakhr Taha PhD, Arash Javeri.
Dopamine Theory of Schizophrenia
Catecholamines (dopamine [DA], norepinephrine [NE], epinephrine [EPI]) 1. Basic Neurochemistry, Chap The Biochemical Basis of Neuropharmacology,
Department of Botany and Plant Pathology Oregon State University
METABOLISM OF 8-ISO-PGF2α IS IMPAIRED BY CLA IN FIBROBLASTS FROM PATIENTS AFFECTED BY X-ALD A. Petroni 1, M. Blasevich 1, R. Carissimi 1, S. Mattavelli.
Effect of oxygen on the Escherichia coli ArcA and FNR regulation systems and metabolic responses Chao Wang Jan 23, 2006.
Drug Metabolism. Evolution of Drug Metabolism As a Science Post WWII Pioneers Richard Tecwyn Williams – Great Britain –1942, worked on the metabolism.
L-DOPA accumulation in astrocytic endfeet surrounding blood vessels. M. Y. INYUSHIN 1, A.HUERTAS, Y. V. KUCHERYAVYKH 1, L. Y. KUCHERYAVYKH 1,V. TSYDIK.
Cytochrome P450 F.G. Guengerich S.D. Black T. Wolff, G. Strobl and H. Greim Sean Ekins F.J. Gonzalez.
Microarrays: Theory and Application By Rich Jenkins MS Student of Zoo4670/5670 Year 2004.
Examination of Age-Related Cholinergic Activity during Nicotine Exposure and Withdrawal Luis M Carcoba, M.D, Ph.D. University of Texas at El Paso Department.
Metabolite Kinetics II
CYP2C8 and Drug Interactions
Dr.farahzadi.1391 dr.farahzadi Overview of Methamphetamine Pharmacology.
Drug Metabolism Overview Dr. Arthur Roberts 1. Where to Find Information eLC – most up to date – correct errors 2.
Drug metabolism Prof. M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General pharmacology.
Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug metabolite ratios in blood Levo et al. Forensic Science International.
Experimental strategies in the study of Metabolism
NEUROCHEMICAL EFFECTS OF STIMULANTS: Relation to their motor effects.
Enzymes Objectives: (a)
Isosteviol derivatives induced apoptosis in Human lung cancer via targeting MEK/MAPK pathway: An in vitro and in vivo study Ahmed M Malki 1,,PhD Stephen.
Polyunsaturated fatty acid synthesis de novo is required for calcium release in vascular smooth muscle N.A.Irvine 1, C.M.Sibbons 1, L.R.Grenfell 1, K.A.Lilycrop.
Intranasal Delivery of Proteins Using Cationic Liposomes for the Treatment of Parkinson’s Disease and the Use of Bioquant ® Image Analysis Software Presented.
BRAIN DELIVERY OF PROTEINS BY THE INTRANASAL ROUTE OF ADMINISTRATION USING CATIONIC LIPOSOMES Presented by Mattia M. Migliore February 23, 2007 Graduate.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Reporter Hung-Jen Hsieh. Non-invasive scintigraphic monitoring of gene expression in a HSV-1 thymidine kinase gene therapy model K.W.MORIN, E.E.KNAUS.
WP 6 UMR de Toxicologie Alimentaire INRA WP6 : Effects of garlic on carcinogen metabolizing enzymes Milestones :  In vitro effects of garlic compounds.
By: Dr. M. M. O. Okonji FRCPsych. (UK) Consultant Psychiatrist.
CYP Biotransformations
Chronic treatment with cannabinoid receptor agonist, CP 55,940, alters GLT1 expression in adolescent rats Introduction Methods Results Selected References.
Maria Rosana Ramirez, PhD, Prof.
CYP2B6 and Drug Interactions FDA Advisory Committee for Pharmaceutical Sciences Clinical Pharmacology Subcommittee November 18th, Zeruesenay Desta.
Simultaneous evaluation of the activity of five cytochrome P450 enzymes by a cocktail study in healthy volunteers Department of Pharmacy Practice & Sciences.
CYP
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
Emmanuelle Germain, Joelle Chevalier, Marlène Steib, Marie-Hélène Siess* and Caroline Teyssier* Institut National de la Recherche Agronomique / ENSBANA,
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Transient Depressive Relapse Induced by Catecholamine.
Cytochrome P 450 Biochemistry Department. Cytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and.
Formation of Hydroxylated Compounds by Microsomal Metabolism of 2,2’,3,3’,6,6’-Hexachlorobiphenyl (PCB-136) Ananya Pramanik, Izabela Kania-Korwel, Jarline.
In Vitro Metabolism and Prediction of Drug-Drug Interaction of the Calcimimetic Agent Cinacalcet HCl Manoj Bajpai, Joel Esmay, Victor Chi, Mike Hayashi,
Time dependent inhibition
An Introduction to Metabolism
Kumari Tripti* and Shardendu
Pharmacology Tutoring – Factors Affecting Drug Action
Mimicking Oxidative Metabolism “OxMet” using ROXY EC System
Neuroscience Drug Discovery DK, H. Lundbeck A/S, Valby, Denmark
METABOLISM OF XENOBIOTICS
Drug Elimination Drug elimination consists of 2 processes
Understanding the Basics of Pharmacology
Volume 59, Issue 4, Pages (April 2001)
Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated.
Amy R Mohn, Raul R Gainetdinov, Marc G Caron, Beverly H Koller  Cell 
Volume 56, Issue 4, Pages (October 1999)
Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1  Chun Liu, Robert M. Russell, Helmut.
Halothane enhances dopamine metabolism at presynaptic sites in a calcium- independent manner in rat striatum  Y.U. Adachi, M. Satomoto, H. Higuchi, K.
Raymond T Bartus, Marc S Weinberg, R. Jude Samulski  Molecular Therapy 
Cytochrome P450 Oxidase Created by Joseph Aman
Volume 73, Issue 11, Pages (June 2008)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 24, Issue 7, Pages e6 (July 2017)
Volume 72, Issue 12, Pages (December 2007)
A Skin-Like Cytochrome P450 Cocktail Activates Prohaptens to Contact Allergenic Metabolites  Moa Andresen Bergström, Hagen Ott, Anna Carlsson, Mark Neis,
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase  Parameswaran Ramakrishnan,
Volume 46, Issue 5, Pages (June 2012)
Resistance to indomethacin-induced down-regulation of hepatic cytochrome P450 enzymes in the mice with non-functional Toll-like receptor 4  Yasuhiro Masubuchi,
Presentation transcript:

PreparationsIsoforms m-tyramine hydroxylation K m [µM] V max [pmol/pmol CYP/min] Cl V max / K m Supersomes (Gentest) ( 0,36 mg protein/ml) Rat CYP2D2 – high reductase Hum. CYP2D6 – high reductase Bactosomes (Cypex) (0,10 mg protein/ml) Rat CYP2D4 – low reductase Rat CYP2D18 – low reductase Hum. CYP2D6 – low reductase Hum. CYP2D6 – high reductase Rat brain microsomes (6 mg protein/ml) PreparationsIsoforms p-tyramine hydroxylation K m [µM] V max [pmol/pmol CYP/min] Cl V max / K m Supersomes (Gentest) ( 0,36 mg protein/ml) Rat CYP2D2 – high reductase Hum. CYP2D6 – high reductase Bactosomes (Cypex) (0,10 mg protein/ml) Rat CYP2D4 – low reductase Rat CYP2D18 – low reductase Rat brain microsomes (6 mg protein/ml) Hydroxylation of tyramine to dopamine Izoenzyme: 1A12A22B12C62C112C132D12D22D42D182E13A2 m-tyramine –––––––+++–– p-tyramine –––––––+++–– Drug CYP2D2 Ki [µM] CYP2D4 Ki [µM] Brain microsomes Ki [µM] fluoxetine1, imipramine2, nefazodoneNo effect5350 mirtazapineNo effect thioridazine0,52,8485 HVA pg/mg tissue ** DOPAC pg/mg tissue ** p<0,01 vs control # p<0,01 vs res ControlRes αMT Res quinine Res αMT parg Res αMT quinine parg** ** # ** # **$ **+ ** ControlRes αMT Res quinine Res αMT parg Res αMT quinine parg ** p<0,01 vs control # p<0,01 vs res $ p<0,01 vs res + α MT + p<0,05 vs res+ α MT + parg DA pg/mg tissue ** ControlRes αMT Res quinine Res αMT parg Res αMT quinine parg ** ** ** # $ ** + ** p<0,01 vs control # p<0,01 vs res $ p<0,01 vs res + α MT + p<0,05 vs res+ α MT + parg Formation of dopamine from tyramine in rat brain microsomes m-tyramine [  M] hum. CYP2D6 Bactosome – low (LR) and high (HR) reductase V 2D6HR 2D6LR dopamine [pmol/pmolCYP/min] S tyramine [  M] m-tyramine p-tyramine S dopamine [pmol/pmolCYP/min] V rat CYP2D18 (Bactosome – low reductase) rat CYP2D4 (Bactosome – low reductase) S m-tyramine p-tyramine dopamine [pmol/pmolCYP/min] tyramine [  M] V m-tyramine p-tyramine S dopamine [pmol/mg protein/min] tyramine [  M] quinine [  M] K i = 250 µM I /V m-tyr [250  M] m-tyr [500  M] m-tyr [1000  M] dopamine [pmol / mg protein / min] mg IgG / mg mikrosomal protein Anty-CYP2D4 IgG Control IgG Activity (% control) Bromek E, Haduch A, Daniel WA Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland Smetna 12, Krakow, Poland CYP2D-SYNTHESIZED DOPAMINE IN THE BRAIN. THE EFFECT OF PSYCHOTROPICS REFERENCES 1.Miksys S, Rao Y, Sellers E M, Kwan M, Mendis D, Tyndale R F: Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica, 2000, 30(6), Hiroi T, Imaoka S, Funae Y: Dopamine formation from tyramine by CYP2D6. Biochem. Biophys.Research Communications, 1998, 249, Hiroi T, Kishimoto W, Chow T, Imaoka S, Igarashi T, Funae Y: Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology, 2001, 142, MATERIALS AND METHODS: 1. Hydroxylation of tyramine to dopamine by cDNA-expressed CYPs: Supersomes (Gentest): - rat 1A1, 2A2, 2B1, 2C6, 2C11, 2C13, 2D1, 2D2, 2E1, 3A2 expressed from rat CYP cDNA using Baculovirus infected insect cells (high expression of NADPH P450 reductase), - human 2D6 expressed from human CYP cDNA using Baculovirus infected insect cells (high expression of NADPH P450 reductase), Bactosomes (Cypex): - rat 2D4, 2D18 - expressed from rat cDNA in Escherichia coli (low expression of NADPH P450 reductase) - human 2D6 - expressed from rat cDNA in Escherichia coli (low or high expression of NADPH P450 reductase) 2. Hydroxylation of tyramine to dopamine by rat brain microsomes: microsome preparation from the whole rat brain [3] inhibitor – quinine (  M) anti-CYP2D4 antibodies ( µg IgG/ml) The amount of dopamine formed in vitro was measured using the HPLC method with electrochemical detection. 3. Hydroxylation of tyramine to dopamine in the brain in vivo: Experimental groups: Control ip Reserpine (10 mg/kg ip) Reserpine + quinine (50 mg/kg ip) Reserpine + α-mehtyl-p-tyrosine (300 mg/kg ip) Reserpine + α-methyl-p-tyrosine + pargyline (150 mg/kg ip) Reserpine + α-methyl-p-tyrosine+ quinine + pargyline The brains were isolated and divided into the structures (nucleus accumbens, substancia nigra, striatum, prefrontal cortex, brain steam, cerebellum, olfactory bulbs and rest of brain) Dopamine and its metabolits were measured using HPLC method. 4. Influence of the selected antidepressant drugs on CYP2D activity: microsome preparation from the whole rat brain cDNA-expressed CYPs (Supersomes CYP2D2 from Gentest, Bactosomes CYP2D4 from Cypex) in the absence and presence of drugs (imipramine, fluoxetine, mirtazapine or nefazodone) added in vitro. Bufuralol and its metabolite 1`-hydroxybufuralol were measured using HPLC with fluorometric detection. CONCLUSIONS: Among the rat CYP isoforms tested only CYP2D2, CYP2D4 and 2D18 were able to form dopamine from tyramine. The rat CYP2D isoforms were less efficient than human CYP2D6. The efficiency of CYP2D2/2D4/2D18 and CYP2D6 to hydroxylate tyramine to dopamine was higher for m-tyramine than p-tyramine. Brain microsomes were able to metabolise tyramine to dopamine, m-tyramine being a more favourite substrate than p-tyramine. The reaction was inhibited by a CYP2D inhibitor – quinine and anti-CYP2D4 antibodies indicating a role of CYP2D in dopamine formation Quinine, a specific CYP2D inhibitor, given to reserpinized rats after inhibition of the classic pathway of dopamine synthesis, decreased dopamine level in the striatum, which indicates dopamine formation from tyramine in the brain in vivo. INTRODUCTION: The CYP2D subfamily of cytochrome P450 in the rat consists of six isoforms (CYP2D1-5 and CYP2D18), whereas in man it has only one representative: isoform CYP2D6. CYP2D4 is regarded as a main CYP2D isoform in rat brain [1]. The CYP2D isoforms which are capable of metabolizing a number of drugs such as psychotropics, the drugs of abuse codeine and amphetamine, and neurotoxins. Furthermore, recent studies suggest that human recombinant CYP2D6 is able to catalyze the formation of dopamine from the endogenous neurochemical substrate tyramine [2]. Since both cytochrome P450 and tyramine are present in the brain, this alternative pathway of dopamine synthesis may contribute to the overall level of this neurotransmitter in the brain. The present study was aimed at determining which rat CYP isoforms (CYPs) were involved in the formation of dopamine from tyramine and wheather the reaction could take place in the brain; moreover, we investigated the influence of the antidepressant drugs imipramine, fluoxetine, mirtazapine and nefazodone on the activity of CYP2D in the brain. Dopamine plays an important role in the pharmacological and therapeutic action of psychotropic drugs. The aim of the present study was to identify and characterize rat CYP2D isoforms engaged in the hydroxylation of tyramine to dopamine, as well as to investigate the effect of selected psychotropics on the activity of CYP2D, assessed by measuring the rate of bufuralol 1’- hydroxylation (HPLC with electrochemical or fluorescent detection, respectively). The study was conducted on rat brain microsomes and two biotechnologically different preparations of c-DNA- expressed CYPs: a) rat CYP2D1 and CYP2D2 and human CYP2D6, (Supersomes, Gentest; a high expression of NADPH P450 reductase); b) rat CYP2D4 and CYP2D18, (Bactosomes, Cypex; a low expression of NADPH P450 reductase). Of the CYP2Ds isoforms tested, only CYP2D1 displayed no activity towards dopamine formation. The efficacy of all the CYP2D isoforms engaged in dopamine formation was higher for m-tyramine than for p-tyramine. The affinity of tyramine for the CYP2D isoforms tested (K m ) was as follows: CYP2D6 > CYP2D2 > CYP2D18 > CYP2D4 for m- tyramine, and CYP2D18 > CYP2D4 > CYP2D2 > CYP2D6 for p-tyramine. The V max values were compared between isoforms with a similar expression of NADPH P450 reductase, i.e. between Supersomes (CYP2D6 > CYP2D2) and Bactosomes (CYP2D4 > CYP2D18), which referred to both m- and p-tyramine. Brain microsomes catalyzed the hydroxylation of tyramine to dopamine, m- tyramine being more efficiently metabolized than p-tyramine. The reaction was inhibited by the CYP2D inhibitor quinine and CYP2D4-directed antibodies, which testifies to the contribution of CYP2D to dopamine formation in the brain. Antidepressants - fluoxetine and imipramine, as well as neuroleptics - thioridazine and perazine decreased the activity of CYP2D in brain microsomes. Using recombinant CYPs, we showed that the investigated psychotropics decreased the activity of CYP2D2 (K i = 1.25, 2.75, 0.5, 17.4  M, respectively) and CYP2D4 (K i = 10, 25, 2.8, 7.1  M, respectively) with different potency. Nefazodone inhibited only CYP2D4 (K i = 5  M), while mirtazapine was not active in this respect. Our study provides direct evidence that dopamine can be formed from tyramine by CYP2D isoforms in rat brain. That alternative pathway may be inhibited by some psychotropics which may affect their pharmacological profile. ABSTRACT: Tyrosine (phenylala.) hydroxylase Classic pathway Alternative pathway Aromatic L-amino acid decarboxylase Tyrosine hydroxylase Aromatic L-amino acid decarboxylase Aromatic L-amino acid decarboxylase rat CYP2D ? brain? dihydroxyphenylalanine phenylalanine tyrosine dopamine phenylethylamine tyramine